|
|
||||||||
Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland 21201-1595
| |
ABSTRACT |
|---|
|
|
|---|
Nitric oxide (NO) generation by the outer medullary descending vasa
recta (OMDVR) was measured with the fluorescent dye
4,5-diaminofluoroscein (DAF-2) during 30-min incubations. Addition of
0.1 or 1.0 mM L-arginine to the incubation buffer increased
the DAF-2 signal by 8.7 and 13.6% (P = 0.08 and
P < 0.05), respectively. Compared with
L-arginine alone (0.1 mM), bradykinin (BK; 1 × 10
7 M) enhanced the DAF-2 signal by 11.1%
(P < 0.05). The NO synthase inhibitor
N
-nitro-L-arginine methyl ester
(0.1 mM) reversed the BK-stimulated NO generation as measured with
either DAF-2 or by the oxidation of Fe2+ hemoglobin. Using
1 mM 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol), a
cell-permeant superoxide dismutase mimetic, we tested whether reduction
of superoxide anion increases intracellular NO. Tempol increased DAF-2
fluorescence by 12 and 23.3%, respectively, over BK-stimulated or
control vessels. Tempol also vasodilated ANG II (1 × 10
8 M)-preconstricted OMDVR (P < 0.05). We conclude that NO generation by isolated OMDVR can be
increased by L-arginine, that the endothelium-dependent vasodilator BK enhances NO production, and that NO consumption by
superoxide plays a role in the determination of cellular NO concentrations.
microperfusion; kidney; hemoglobin; fura 2; tempol; bradykinin; arginine
| |
INTRODUCTION |
|---|
|
|
|---|
DESCENDING VASA RECTA (DVR) are small generation resistance vessels that carry blood from the cortex to the medulla of the kidney. DVR originate as branches of the juxtamedullary efferent arteriole and traverse the outer medulla in vascular bundles. The DVR that supply the inner and outer medulla are radially arranged within the bundles from center to periphery, respectively. This parallel arrangement strongly suggests that the DVR distribute and regulate regional blood flow within the medulla (17, 26). DVR are enveloped by small contractile cells called pericytes (29) and are lined by a continuous endothelium. The importance of endothelial secretion of paracrine mediators to modulate the contractility of adjacent smooth muscle is well established. Motivated by the importance of nitric oxide (NO) in the maintenance of medullary perfusion and blood pressure (9, 16, 18-21, 24, 37, 38), we adapted two methods for measuring NO production by DVR that were isolated and dissected from vascular bundles of the outer medulla of the kidney. First, the probe 4,5-diaminofluoroscein (DAF-2), which increases fluorescence with covalent modification by NO, was used to monitor NO generation (5, 13). To corroborate the findings with DAF-2, we employed a second microincubation scheme to monitor the oxidation of the Fe2+ (ferrous) to Fe3+ (ferric) hemoglobin (Hb2+ and Hb3+, respectively) by NO (1, 23). The results verified that isolated DVR generate NO and that NO production is increased by supplying L-arginine or stimulating with the endothelium-dependent vasodilator bradykinin (BK). Reduction of superoxide anion with the cell-permeant superoxide dismutase mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol) also increased NO in isolated DVR.
| |
METHODS |
|---|
|
|
|---|
Isolation of outer medullary descending vasa recta. Kidneys were harvested from Sprague-Dawley rats (70-150 g body wt; Harlan), sliced, placed in buffer, and maintained on ice at 0-4°C. Outer medullary DVR (OMDVR) were dissected from vascular bundles and transferred to the stage of an inverted microscope as previously described (25-28). The buffer used for dissection and the bath in these studies included (in mM) 140 NaCl, 10 NaC2H3O2, 5 KCl, 1.2 MgCl2, 2 Na2HPO4/NaH2PO4, 1 CaCl2, 5 alanine, 5 glucose, and 5 HEPES and 0.5 g/dl of albumin (pH = 7.4).
Fluorescent detection of NO with diaminofluorescein
diacetate probe.
The nonfluorescent molecule DAF-2 diacetate (DAF-2DA) becomes
weakly fluorescent when loaded into cells via deesterification to form
DAF-2. DAF-2 further increases in fluorescence when it is covalently
modified by NO to yield a triazofluorescein (5, 13). Thus
the fluorescent signal from DAF-2 produces an integrated measure of
local NO concentration ([NO]) within the loaded cells. DAF-2 was
excited at 485 nm using a xenon arc lamp (Photon Technology International; Lawrenceville, NJ). Fluorescent emission was isolated with a band-pass filter at 530 nm (Omega Optical; Brattleboro, VT) and
measured with a photon-counting detection assembly (D104B; Photon
Technology International). Each OMDVR was transferred to the imaging
chamber, where the ends were aspirated into a pair of holding
pipettes that had openings of 10-15 µm. The pipettes and vessel
were positioned using micromanipulators (Instruments Technology and
Machinery; San Antonio, TX) mounted on an inverted microscope (Nikon
Diaphot). The OMDVR were positioned near a thermocouple in the narrow
inlet region of a custom-built chamber. Temperature was maintained with
a feedback system (CN9000A; Omega Engineering; Bridgeport, NJ). The
vessel was warmed to 37°C and loaded for 20 min with 10 µM DAF-2DA
ester. DAF-2 loads into both endothelia and pericytes (see Fig.
1, A-C) and increases
emission at 530 nm during excitation between 450 and 500 nm without a
spectral shift (see Fig. 1D).
|
Measurement of NO generation with oxyhemoglobin.
As a second method to verify NO generation by isolated OMDVR, we
employed the property of NO to oxidize Hb from the Hb2+
form to the Hb3+ form (1, 23). When this
oxidation occurs, the absorption spectrum of Hb shifts, thereby
permitting a measure of the extent of the oxidation. A microincubation
scheme was devised to take advantage of this property. To serve as a
cuvette for monitoring the conversion of Hb2+ by isolated
OMDVR, a standard microperfusion-style holding pipette was created but
markedly enlarged to ~2 mm in length and ~75 µm in diameter. The
cuvette tip was heat polished to reduce the diameter of the entrance to
~50 µm. Light was passed from a fiber-optic filament through the
cuvette as shown in Fig. 2. The 250-µm
fiber-optic filament (Edmond Scientific; Barrington, NJ) was modified
by drawing it out under heat on a microforge (Stoelting; Wood Dale, IL)
and cutting the taper with a razor blade to obtain a tip diameter of
~50 µm. The end of a length of stainless steel music wire (Small Parts; Miami Lakes, FL) was then polished to a mirror finish with 0.3-µm grit sandpaper (Thomas Scientific; Swedesboro, NJ) and held at
a 30° angle to reflect the transmitted light to the microscope objective. The light collected by the objective was measured with a
photon-counting photomultiplier detection assembly (Photon Technology International) attached to the side port of the microscope. A coupling
was machined from aluminum that permitted insertion of the far end of
the filament into the exit slit of a computer-controlled monochrometer
(Photon Technology International). Thus the wavelength of light for the
measurement of transmittance could be continuously varied as the
transmission through the microcuvette was monitored. In place of a
standard perfusion pipette, the fiber-optic filament was fixed to a
standard acrylic perfusion-pipette holding assembly (Instruments
Technology Machinery; San Antonio, TX) so that it could be advanced in
and out of the constriction by turning a screw. The filament tip was
withdrawn as needed to allow aspiration of buffer containing Hb or
several OMDVR into the cuvette area. When replaced into the
constriction, the fiber-optic tip provided a good seal that prevented
movement of buffer in and out of the cuvette.
|
Measurement of endothelial intracellular Ca2+. The OMDVR were loaded with the Ca2+-sensitive fluorescent indicator fura 2 by exposure to a bath containing 2 µM fura 2-acetoxymethyl ester (Molecular Probes; Eugene, OR) for 20 min (25, 27). We have previously shown (25) that fura 2 preferentially loads into endothelial cells rather than pericytes. For measurement of intracellular Ca2+ concentration ([Ca2+]i), fura 2-loaded OMDVR were excited using 350- and 380-nm dual-wavelength combinations. The background-subtracted ratio of fluorescent emission (R350/380) was calculated for conversion to the equivalent [Ca2+]i assuming a dissociation constant for fura 2 at 37°C of 224 nM. The ratio when fura 2 is completely calcium bound (Rmax) and the ratio in calcium-free solution (Rmin) were measured as previously described by exposing vessels to buffer containing 5 mM CaCl2 or 0 CaCl2 and 0.5 mM EGTA, respectively, along with 10 µM 4-bromo-A-23187, a Ca2+ ionophore (25, 27).
Videomicroscopy and measurement of vessel diameters. To quantify vasoconstriction, microperfusion experiments were captured on videotape using a video camera (WV-BL90; Panasonic). Experiments were recorded on a video cassette recorder (AG-1960; Panasonic) equipped with a microphone for voice recording and were played back to enable diameter measurement via calipers. As previously described, changes in vessel outer diameter are expressed as percent constriction (25, 27, 36).
Reagents.
DAF-2 DA (5 mM in DMSO) was purchased from Calbiochem (La Jolla, CA)
and stored at
20°C; it was diluted to 10 µM to load OMDVR. Sodium
nitroprusside (SNP), BK,
N
-nitro-L-arginine methyl ester
(L-NAME), L-arginine, and tempol were purchased
from Sigma. SNP was dissolved just before experimentation and was
protected from light. BK, L-NAME, and
L-arginine were dissolved in water and stored in 1 × 10
4 M, 100 mM, and 100 mM concentrations, respectively,
at
20°C and in 100-µl aliquots. Stock frozen solutions were
thawed on the day of the experiment, and the excess was discarded. In a manner similar to that described by Zou and colleagues (37, 38), human Hb2+ was purchased from Sigma as a
lyophilized powder and was dissolved in buffer on the day of experimentation.
Statistics. Data are shown as means ± SE. Statistical testing employed Student's t-test (paired or unpaired, as appropriate) and ANOVA. With ANOVA, the Student-Newman-Keuls test was used to examine significance.
| |
RESULTS |
|---|
|
|
|---|
Reaction of DAF-2 with exogenous NO.
In the first series of experiments, we verified the ability of DAF-2
(loaded into isolated OMDVR) to increase fluorescence during exogenous
NO production by SNP. As shown in Fig. 3
(left), OMDVR loaded with DAF-2 increased
background-subtracted fluorescence by ~30% over 10 min. Time
controls showed a slow decline in fluorescence. The decline in signal
emitted from the controls cannot be interpreted as a lack of NO
generation but does imply that the rate of loss of the dye due to
leakage exceeded the rate of fluorescence increase due to basal rates
of NO generation.
|
log
(T/T1), where
T1 is the transmittance in the absence of Hb.
The difference between Hb2+ and Hb3+ absorbance
was linear with Hb concentration at all wavelengths and was most
sensitive at 400 nm (increased absorbance) or 420 nm (reduced
absorbance), as shown in Fig. 4C. Exogenous production of NO
with SNP (0.5 mM) yielded the results shown in Fig. 4D where T, normalized to that at time 0 (T0), is shown as a function of time after
drawing SNP + Hb2+ solution (5 µM) into the cuvette.
The anticipated increase in transmittance at 420 nm was observed.
|
Endogenous production of NO: effects of L-arginine.
Measurement of endogenous NO production in DAF-2-loaded vessels proved
feasible but required longer observation periods than were employed
with SNP (see Fig. 3). We first asked whether the supply of the NO
synthase (NOS) substrate L-arginine affected basal NO
generation in this isolated vessel preparation. Overall DAF-2
fluorescence declined with time in control vessels that were not
supplied with L-arginine. As illustrated (see Fig.
5, left) and summarized (see
Fig. 5, right), addition of 0.1 mM L-arginine tended to enhance the DAF-2 signal compared with controls, but the
effect did not achieve significance (P = 0.08).
Addition of 1 mM L-arginine yielded a slightly increasing
signal that achieved significance compared with the controls
(P < 0.05; Fig. 5, right).
|
Endogenous production of NO with BK.
To test the ability of the endothelium-dependent vasodilator BK to
stimulate NO production, vessels loaded with DAF-2 were exposed to a
bath containing 0.1 mM L-arginine with or without BK
(1 × 10
7 M). BK resulted in an enhancement of DAF-2
fluorescence compared with controls, but a relatively large number of
observations were required to achieve significance (see Fig.
6, A and B). NO
production was also examined at lower BK concentrations (1 × 10
10 and 5 × 10
9 M; n = 7 each). DAF-2 fluorescence was 99 and 102% of control, respectively, neither of which achieved significance. We also verified
that L-NAME (1 × 10
4 M) inhibits
BK-stimulated NO production (see Fig. 6, C and
D). The results during continuous excitation were similar to
those obtained when excitation light was blocked with a shutter during most of the experiment, which verified that dye leakage rather than
photobleaching accounted for the slow decline of the signal (see Fig.
6, E and F).
|
4 M) blocked BK
(1 × 10
7 M)-stimulated NO production as monitored
by the transmittance at 420 nm.
|
|
Effect of tempol on [NO] within isolated OMDVR.
Because oxygen free radicals are produced by a variety of endogenous
enzymes and consume NO, we tested the hypothesis that local [NO]
within cells of OMDVR would increase in the presence of a superoxide
dismutase mimetic. Tempol was chosen because it is cell permeant, and
it functions as a superoxide dismutase mimetic (10, 30).
Inclusion of tempol (1 mM) in the bath tended to enhance DAF-2
fluorescence compared with controls, but the effect did not achieve
significance (data not shown; P = 0.08;
n = 6 and 9 for controls and tempol, respectively).
When BK (1 × 10
7 M) was also used to stimulate NO
production, significant increases in DAF-2 fluorescence were readily
observed with tempol compared with unstimulated (P < 0.01) or BK-stimulated (P < 0.05) vessels (see Fig.
9). A series of experiments were also
performed to determine whether the addition of tempol (1 mM) would have
an effect on the ability of SNP (0.95 mM) to increase the fluorescence
of DAF-2 loaded into OMDVR. With tempol, fluorescence increased by
12.2 ± 1.3% in 10 min (n = 7). In the absence of
tempol, fluorescence increased by 7.7 ± 1.7% in 10 min
(n = 7; P = 0.06 vs. tempol). We also
tested the ability of tempol (1 mM) to dilate OMDVR that had been
preconstricted by ANG II (1 × 10
8 M). After we
obtained baseline diameter measurements, ANG II was added to the bath
for 5 min. Thereafter, either tempol or vehicle was exchanged into the
bath for 5 min and then washed out for 5 min. Tempol dilated
preconstricted vessels whether or not L-arginine (1 × 10
4 M) was included in the bath (see Fig.
10).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Substantial evidence has been accumulated to show that perfusion of the renal medulla is sensitive to blockade of NO synthesis. Systemic infusion of L-arginine corrects abnormal pressure natriuresis and medullary autoregulation in spontaneously hypertensive rats (16, 18). Intravenous infusion of L-NAME into conscious rats induces hypertension, sodium retention, and reduction of medullary blood flow yet spares perfusion of the renal cortex (24). Selective infusion of L-NAME into the interstitium of the kidney of uninephrectomized rats also caused both hypertension and the selective reduction of medullary blood flow (20, 21). Hypertension was induced by the inhibition of neural NOS (nNOS) expression via interstitial infusion of antisense oligonucleotides or by inhibition of nNOS activity via interstitial infusion of a selective inhibitor (19). Recent experiments with the juxtamedullary nephron technique (12) confirmed roles for nNOS in affecting responsiveness of the afferent arteriole (due to alteration of tubuloglomerular feedback) and in affecting efferent arteriolar constriction (via intrinsic effects).
The study of regulation by NO most often depends on observation of the biological effects of nonspecific or isoform-specific NOS blockade. NO generation at the level of single cells or groups of cells is difficult to measure. Such measurements have been performed in isolated microvessels and nephron segments with microelectrodes (33) and through the determination of the conversion of L-[3H]arginine to citrulline by NOS (35). Isolated OMDVR are very small microvessels (diameter, 15 µm; length, 500 µm), respectively. As such, detection of NO generation presents a similar challenge. In this study, we investigated the feasibility of using the fluorescent probe DAF-2 for this purpose. The dye successfully detected exogenous NO donation by SNP (see Fig. 3) and endogenous NO production by OMDVR (see Figs. 5, 6, and 9). The greatest limitation was the tendency of DAF-2 to leak from the vessels after being trapped by deesterification. Our experience with losses of fura 2 after loading of the OMDVR with the ester was similar (25, 27). Fura 2 and similar probes are more forgiving, because dual-wavelength ratios compensate for and hide the effects of losses due to leakage. DAF-2 fluorescence is measured at a single wavelength so that leakage is directly superimposed on the data records. A competition between loss of signal due to leak and enhancement of fluorescence by NO determines the maximum observation time and therefore our overall ability to discern the effects of an experimental perturbation. Also, the reaction of DAF-2 with NO produced an irreversible covalent modification; therefore, repeated observations on a single vessel could not be readily performed. In summary, to measure the event of interest, sufficient NO modification of the dye must occur on a time scale that is shorter than the rate of loss due to leakage, and only group comparisons are possible. Despite this difficulty, we found that properly designed studies with DAF-2 can yield useful measurement of the modulation of NO generation in isolated OMDVR.
To provide independent verification of NO generation by another method, we also adapted a microincubation scheme that allows conversion of Hb2+ to Hb3+ by NO released from isolated vessels (see Fig. 2). In this approach, the electron released by Hb2+ to NO during the degradation causes a shift in the absorption spectrum that is most efficiently monitored at either 400 or 420 nm (see Fig. 4) or by taking the difference between the transmittance values at these two wavelengths (1, 23). Once again the method is feasible but difficult. The greatest limitation is the simple inability to obtain stable placement of the vessel(s) within the pipette holding area/cuvette. Exchange of the volume of Hb2+ in the cuvette generally dislodges or alters the location of the vessel so that repeated paired comparisons cannot be meaningfully performed. The effects of Hb on oxygen tension within the cuvette area are unknown and cannot be readily controlled. In view of this, there is also concern that the rapid local consumption of NO by Hb2+ might enhance activation of NOS independent of the experimental perturbations. Theoretically, variations in NO production due to manipulations that occur more rapidly than the time required for diffusion of NO across the cuvette might not be accurately measured, because diffusion away from the vessel would dominate over NO production as the rate-limiting step. This is unlikely to be a problem, because NO diffusivity (D) is high. For D = 3,300 µm2/s at 37°C in water (15) and a cuvette of diameter d = 50-100 µm, it is expected that a characteristic diffusion time of ~d2/D = 3 s would exist. Thus events occurring on a scale of minutes can be measured. In keeping with this notion, we were able to document the blockade of NO generation in BK-stimulated OMDVR (see Fig. 8). In general, measurements with DAF-2 are easier to perform and do not suffer from the concern over Hb activation. Our extensive use of DAF-2 in this study reflects our preference for that method. The possibility of extending either of these methods to the study of NO generation in isolated nephron segments has not been explored but does seem inviting.
Intracellular L-arginine concentrations are reported (2) to be in the range of 100-800 µM, which are values that are much greater than the ~10 µM substrate requirement of endothelial NOS. Based on this consideration, it is not anticipated that high concentrations of L-arginine would affect the rate of NO generation. In contrast, increasing the extracellular concentration of L-arginine has been repeatedly shown (6) to enhance NO generation; this finding has been dubbed the "arginine paradox" (14). In a previous study (25), we showed that BK-induced vasodilation could be augmented by including L-arginine in the bath of microperfused OMDVR. The results illustrated in Fig. 5 support this finding and verify that NO generation by isolated OMDVR can be enhanced by L-arginine. It has been proposed (14) that L-arginine might reside within intracellular pools sequestered from NOS and that NOS isoforms could be spatially linked to membrane L-arginine transporters. The finding that L-arginine infusion can modulate medullary perfusion and pressure natriuresis (16) coupled with the existence of L-arginine-facilitated transport systems in the medulla (8) raise the possibility that specific recycling mechanisms serve to regulate vasomotion of DVR within vascular bundles through local alterations of interstitial L-arginine concentration.
It is generally accepted that NO is a short-lived molecule, the effects of which are exerted within several micrometers of the site of synthesis. Local levels of superoxide anion regulate the availability of NO by reacting with NO to produce peroxynitrite (3, 7). This process has been implicated in exaggerated vasoactivity in spontaneously hypertensive rats (31) and has been shown to affect vasoconstriction of the afferent arteriole in rabbits (32). In support of the possibility that [NO] within the OMDVR wall is also modulated by superoxide, we found that treatment with the cell-permeant superoxide dismutase mimetic tempol substantially augmented the detection of NO during BK stimulation (11, 31, 32) (see Fig. 9). Tempol also increased DAF-2 fluorescence when SNP was the NO donor (P = 0.06). The latter finding is consistent with the hypothesis that tempol reduces the consumption of SNP-donated NO by superoxide anion; however, a specific effect on the release of NO from SNP by NADPH oxidase cannot be ruled out (21). The functional significance of the tempol effect was also investigated in ANG II-constricted OMDVR (see Fig. 10); tempol vasodilated the preconstricted vessels whether or not L-arginine was included in the bath.
We previously observed a tendency for ANG II to reduce endothelial [Ca2+]i in fura 2-loaded OMDVR (27). The ability of tempol to vasodilate OMDVR, presumably through enhancement of [NO], implies that there is ongoing NO production in the presence of ANG II. Another possibility is that some NOS isoform is expressed within the pericytes where ANG II almost certainly increases [Ca2+]i during vasoconstriction. We previously observed (36) that nonspecific NOS inhibitors, when applied alone, constrict OMDVR. That finding supports the functionally significant NO production in unstimulated vessels.
In the absence of Hb and oxygen, the half-life of NO can be quite long (3). A competing effect in this scenario is the requirement of oxygen as a substrate for NOS during NO generation from L-arginine (34). Whether local NO levels would tend to increase during hypoxia due to reduced destruction by superoxide anion or decrease due to reduced NO generation resulting from oxygen-substrate limitation is uncertain. The net result might depend locally on the expression and behavior of enzymes such as NADPH oxidase that generate reactive oxygen species (7). The potential interactions are clearly complex, however, given the low PO2 (4) and the low Hb concentration of blood within the renal medulla (26). The possibility can be entertained that NO might accumulate to high levels and diffuse far enough to have distant effects.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institutes of Health Grants DK-42495 and HL-62220.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: T. L. Pallone, Div. of Nephrology, N3W143, Univ. of Maryland at Baltimore, Baltimore, MD 21201-1595 (E-mail: tpallone{at}medicine.umaryland.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 29 August 2000; accepted in final form 14 February 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Archer, S.
Measurement of nitric oxide in biological models.
FASEB J
7:
349-360,
1993[Abstract].
2.
Baydoun, AR,
Emery PW,
Pearson JD,
and
Mann GE.
Substrate dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells.
Biochem Biophys Res Commun
173:
940-948,
1990[Web of Science][Medline].
3.
Beckman, JS,
and
Koppenol WH.
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly.
Am J Physiol Cell Physiol
271:
C1424-C1437,
1996
4.
Brezis, M,
Heyman SN,
Dinour D,
Epstein FH,
and
Rosen S.
Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys.
J Clin Invest
88:
390-395,
1991.
5.
Brown, LA,
Key BJ,
and
Lovick TA.
Bio-imaging of nitric oxide-producing neurons in slices of rat brain using 4,5-diaminofluorescein.
J Neurosci Methods
92:
101-110,
1999[Web of Science][Medline].
6.
Buckley, BJ,
Mirza Z,
and
Whorton AR.
Regulation of Ca2+ dependent nitric oxide synthase in bovine aortic endothelial cells.
Am J Physiol Cell Physiol
269:
C757-C765,
1995
7.
Chagriya, K,
and
Wilcox CS.
Antioxidants for hypertension.
Curr Opin Nephrol Hypertens
7:
531-538,
1998[Web of Science][Medline].
8.
Dantzler, WH,
and
Silbernagl S.
Basic amino acid transport in renal papilla: microinfusion of Henle's loops and vasa recta.
Am J Physiol Renal Fluid Electrolyte Physiol
265:
F830-F838,
1993
9.
Fenoy, FJ,
Ferrer P,
Carbonell L,
and
Garcia-Salom M.
Role of nitric oxide on papillary blood flow and pressure natriuresis.
Hypertension
25:
408-414,
1995
10.
Hahn, SM,
Sullivan FJ,
DeLuca AM,
Bacher JD,
Liebmann J,
Krishna MC,
Coffin D,
and
Mitchell JB.
Hemodynamic effect of the nitroxide superoxide dismutase mimics.
Free Radic Biol Med
27:
529-535,
1999[Web of Science][Medline].
11.
Iannone, A,
Bini A,
Swartz HM,
Tomasi A,
and
Vannini V.
Metabolism in rat liver microsomes of the nitroxide spin probe tempol.
Biochem Pharmacol
38:
2581-2586,
1989[Web of Science][Medline].
12.
Ichihara, A,
Inscho EW,
Imig JD,
and
Navar LG.
Neuronal nitric oxide synthase modulates rat renal microvascular function.
Am J Physiol Renal Physiol
274:
F516-F524,
1998
13.
Kojima, H,
Nakatsubo N,
Kikuchi K,
Urano Y,
Higuchi T,
Tanaka J,
Kudo Y,
and
Nagano T.
Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA.
Neuroreport
9:
3343-3348,
1998.
14.
Kurz, S,
and
Harrison DG.
Insulin and the arginine paradox.
J Clin Invest
99:
369-370,
1997[Web of Science][Medline].
15.
Lancaster, JR, Jr.
Diffusion of free nitric oxide.
Methods Enzymol
268:
31-38,
1996[Web of Science][Medline].
16.
Larson, TS,
and
Lockhart JC.
Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F907-F912,
1995
17.
Lemley, KV,
and
Kriz W.
Cycles and separations: the histotopography of the urinary concentrating process.
Kidney Int
31:
538-548,
1987[Web of Science][Medline].
18.
Lockhart, JC,
Larson TS,
and
Knox FG.
Perfusion pressure and volume status determine the microvascular response of the rat kidney to N
-monomethyl-L-arginine.
Circ Res
75:
829-835,
1994
19.
Mattson, DL,
and
Bellehumeur TG.
Neural NO synthase in the renal medulla and blood pressure regulation.
Hypertension
28:
297-303,
1996
20.
Mattson, DL,
Lu S,
Nakanishi K,
Papanek PE,
and
Cowley AW, Jr.
Effect of chronic renal medullary nitric oxide inhibition on blood pressure.
Am J Physiol Heart Circ Physiol
266:
H1918-H1926,
1994
21.
Mattson, DL,
Roman RJ,
and
Cowley AW, Jr.
Role of nitric oxide in renal papillary blood flow and sodium excretion.
Hypertension
19:
766-769,
1992
22.
Mohazzab-H, KM,
Kaminski PM,
Agarwal R,
and
Wolin MS.
Potential role of a membrane bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside.
Circ Res
84:
220-228,
1999
23.
Murphy, ME,
and
Noack E.
Nitric oxide assay using hemoglobin method.
Methods Enzymol
233:
240-250,
1994[Web of Science][Medline].
24.
Nakanishi, K,
Mattson DL,
and
Cowley AW, Jr.
Role of renal medullary blood flow in the development of L-NAME hypertension in rats.
Am J Physiol Regulatory Integrative Comp Physiol
268:
R310-R316,
1995.
25.
Pallone, TL,
Silldorff EP,
and
Cheung JY.
Response of isolated descending vasa recta to bradykinin.
Am J Physiol Heart Circ Physiol
274:
H752-H759,
1998
26.
Pallone, TL,
Silldorff EP,
and
Turner MR.
Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion.
Clin Exp Pharmacol Physiol
25:
383-392,
1998[Web of Science][Medline].
27.
Pallone, TL,
Silldorff EP,
and
Zhang Z.
Inhibition of calcium signaling in descending vasa recta endothelia by ANG II.
Am J Physiol Heart Circ Physiol
278:
H1248-H1255,
2000
28.
Pallone, TL,
Work J,
Myers RL,
and
Jamison RL.
Transport of sodium and urea in renal outer medullary vascular bundles.
J Clin Invest
93:
212-222,
1994.
29.
Park, F,
Mattson DL,
Roberts LA,
and
Cowley AW, Jr.
Evidence for the presence of smooth muscle
-actin within pericytes of the renal medulla.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1742-R1748,
1997
30.
Samuni, A,
Mitchell JB,
DeGraff W,
Krishna CM,
Samuni U,
and
Russo A.
Nitroxide SOD-mimics: modes of action.
Free Radic Res Commun
12:
187-194,
1991.
31.
Schnackenberg, GC,
Welch WJ,
and
Wilcox CS.
Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic. Role of nitric oxide.
Hypertension
32:
59-64,
1998
32.
Schnackenberg, GC,
Welch WJ,
and
Wilcox CS.
TP receptor-mediated vasoconstriction in microperfused afferent arterioles: roles of O
33.
Thorup, C,
Kornfeld M,
Winaver JM,
Goligorsky MS,
and
Moore LC.
Angiotensin II stimulates nitric oxide release in isolated perfused renal resistance arteries.
Pflügers Arch
435:
432-434,
1998[Web of Science][Medline].
34.
Whorton, AR,
Simonds DB,
and
Piantadosi CA.
Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells.
Am J Physiol Lung Cell Mol Physiol
272:
L1161-L1166,
1997
35.
Wu, F,
Park F,
Cowley AW, Jr,
and
Mattson DL.
Quantification of NO synthase activity in microdissected segments.
Am J Physiol Renal Physiol
276:
F874-F881,
1999
36.
Yang, S,
Silldorff EP,
and
Pallone TL.
Effect of norepinephrine and acetylcholine on outer medullary descending vasa recta.
Am J Physiol Heart Circ Physiol
269:
H710-H716,
1995
37.
Zou, AP,
Wu F,
and
Cowley AW, Jr.
Protective effect of angiotensin II induced increase in nitric oxide in the renal medullary circulation.
Hypertension
31:
271-276,
1997[Web of Science].
38.
Zou, AP,
and
Cowley AW, Jr.
Nitric oxide in renal cortex and medulla. An in vivo microdialysis study.
Hypertension
29:
194-198,
1997
This article has been cited by other articles:
![]() |
C. Cao, K. Payne, W. Lee-Kwon, Z. Zhang, S. W. Lim, J. Hamlyn, M. P. Blaustein, H. M. Kwon, and T. L. Pallone Chronic ouabain treatment induces vasa recta endothelial dysfunction in the rat Am J Physiol Renal Physiol, January 1, 2009; 296(1): F98 - F106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pittner, K. Rhinehart, and T. L. Pallone Ouabain modulation of endothelial calcium signaling in descending vasa recta Am J Physiol Renal Physiol, October 1, 2006; 291(4): F761 - F769. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lee-Kwon, J. B. Wade, Z. Zhang, T. L. Pallone, and E. J. Weinman Expression of TRPC4 channel protein that interacts with NHERF-2 in rat descending vasa recta Am J Physiol Cell Physiol, April 1, 2005; 288(4): C942 - C949. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, G. Solis, J. Pittner, W. Lee-Kwon, W. J. Welch, C. S. Wilcox, and T. L. Pallone Chronic ANG II infusion increases NO generation by rat descending vasa recta Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H29 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, T. Pibulsonggram, and A. Edwards Determinants of basal nitric oxide concentration in the renal medullary microcirculation Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1189 - F1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang and T. L. Pallone Response of descending vasa recta to luminal pressure Am J Physiol Renal Physiol, September 1, 2004; 287(3): F535 - F542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, W. Kwon, E. Weinman, and T. L. Pallone ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H773 - H781. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Cardiovascular and renal control in NOS-deficient mouse models Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R628 - R638. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mattson Importance of the renal medullary circulation in the control of sodium excretion and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R13 - R27. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, and T. L. Pallone Membrane potential controls calcium entry into descending vasa recta pericytes Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R949 - R957. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rhinehart, Z. Zhang, and T. L. Pallone Ca2+ signaling and membrane potential in descending vasa recta pericytes and endothelia Am J Physiol Renal Physiol, October 1, 2002; 283(4): F852 - F860. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, A. M. Gutierrez, A. Ring, and A. E. G. Persson Nitric Oxide Induces Resensitization of P2Y Nucleotide Receptors in Cultured Rat Mesangial Cells J. Am. Soc. Nephrol., February 1, 2002; 13(2): 313 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Schnackenberg Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R335 - R342. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |